0000000000752621

AUTHOR

Catia Angiolini

showing 2 related works from this author

Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials

1997

Summary Background Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death. Many treatments have been proposed but considerable uncertainty still remains about their effectiveness. In this review we evaluated the quality, clinical coherence, consistency and results of Randomized Controlled Trials (RCT) of non-surgical treatments for HCC. Methods Thirty-seven RCTs examining the effect of different treatments were retrieved using MEDLINE (November 1978 to December 1995) and a review of reference lists. Selected aspects of the quality of design, conduct and reporting were examined. The odds ratio for the probability of surviving up to one year was calculated according to the …

Malemedicine.medical_specialtyCarcinoma Hepatocellularmedicine.medical_treatmentlaw.inventionRandomized controlled triallawInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineAdjuvant therapyHumansEmbolizationRandomized Controlled Trials as Topicbusiness.industryArterial EmbolizationLiver NeoplasmsHematologyOdds ratioEmbolization TherapeuticChemotherapy regimenSurgeryClinical trialClinical Trials Phase III as TopicOncologyMeta-analysisImmunotherapybusinessAnnals of Oncology
researchProduct

Patterns of care and cost profiles of women with breast cancer in Italy: EPICOST study based on real world data

2020

Objectives To estimate total direct health care costs associated to diagnosis and treatment of women with breast cancer in Italy, and to investigate their distribution by service type according to the disease pathway and patient characteristics. Methods Data on patients provided by population-based Cancer Registries are linked at individual level with data on health-care services and corresponding claims from administrative databases. A combination of cross-sectional approach and a threephase of care decomposition model with initial, continuing and final phases-of-care defined according to time occurred since diagnosis and disease outcome is adopted. Direct estimation of cancer-related cost…

medicine.medical_specialtyReal world dataTotal costEconomics Econometrics and Finance (miscellaneous)PopulationHealth care utilizationAdministrative dataBreast NeoplasmsSettore MED/42 - Igiene Generale E Applicata03 medical and health sciencesInsurance Claim Review0302 clinical medicineBreast cancerBreast cancerEnvironmental healthHealth careCost analysiCost analysisMedicineHumans030212 general & internal medicineRegistrieseducationRetrospective Studieseducation.field_of_studyHealth economicsbusiness.industry030503 health policy & servicesHealth PolicyPublic healthmedicine.diseaseHospitalizationCross-Sectional StudiesItalyCost driverCohortFemaleHealth Expenditures0305 other medical sciencebusinessDelivery of Health Care
researchProduct